Off‐label and unlicensed medicines to hospitalised children in Norway
نویسندگان
چکیده
OBJECTIVES The aim of this study was to investigate the use of off-label (OL) and unlicensed (UL) medicines to hospitalised children in Norway, to add to the current knowledge on use of medicines in this vulnerable patient group. METHODS The study was performed as a cross-sectional prospective study. Medication was classified as on- or off-label based on the comparison with the SmPC regarding age, indication, dosage, route of administration and handling of the product. UL products were classified as imported or pharmacy produced. KEY FINDINGS More than 90% of children receiving medicines in our study were given OL or UL medicines. More patients received OL (83%) than UL (59%). Route of administration was the most frequently observed OL category. The vast majority of the OL prescriptions were for 'off-patent' products. One-third of products prescribed were UL. CONCLUSIONS The study confirms that medicines to children in hospital to a significant degree are being used outside or without authorisation, in spite of recent paediatric regulatory initiatives. More data are still needed on efficacy and safety of medicines used in children, data to be incorporated in the SmPC. In addition, suitable formulations are needed to ensure optimal dosing and adherence without risky manipulations.
منابع مشابه
Unlicensed and off-label drug use in children: implications for safety.
Throughout the world, many drugs prescribed for children are used in an off-label or unlicensed manner. The incidence of unlicensed and off-label drug prescriptions appears to be greatest in critically ill neonates and children and lowest in the general population. The risk associated with unlicensed and off-label drug use appears to be greater than for prescribing in accordance with the produc...
متن کاملEssential drugs for infants and children: European perspective.
It is difficult to draw up a list of medicines that are essential for infants and children. It is clear, however, that many of the medicines used appropriately to treat infants and children are not licensed for such use.1 The medicines concerned may be used outside the terms of their product license, ie, used off-label, or unlicensed for use in children at any age.2 Off-label use appears to be ...
متن کاملUnlicensed and off-label medicines and prescriptions: A descriptive analysis of the medicines formulary and of the 56,800 prescriptions in a paediatric hospital
Introduction: There are not enough medicines approved for paediatric use. A very large number of prescriptions are unlicensed or off-label in different countries, diseases and patient ages. Methods: The aim of our retrospective observational study was to analyse the proportion of unlicensed and off-label prescriptions in a paediatric University Hospital Centre (UHC) over a period of six months ...
متن کاملEuropean Medicines Agency Pre-authorisation Evaluation of Medicines for Human Use
Very few publications specifically address the issue of off label and/or unlicensed medicines. Underreporting is the case for paediatric adverse drug reactions (ADR’s) as for adults, but may be even more common for unlicensed, off-label medicines. In contrast to spontaneous reporting, prospective monitoring of ADR’s indicates higher incidence and in particular shows up to double incidence when ...
متن کاملUnlicensed and off-label medication use in a general pediatrics ambulatory hospital unit in Israel.
BACKGROUND Many medications used for children have not undergone evaluation to assure acceptable standards for optimal dose, safety and efficacy. As a result, the majority of children admitted to hospital wards receive medications outside the terms of their license (off-label) or medications that are not specifically licensed for use in children (unlicensed). The extent of unlicensed and off-la...
متن کامل